Joseph Colofiore

400 total citations
24 papers, 329 citations indexed

About

Joseph Colofiore is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph Colofiore has authored 24 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph Colofiore's work include Biochemical and Molecular Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Joseph Colofiore is often cited by papers focused on Biochemical and Molecular Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Joseph Colofiore collaborates with scholars based in United States and Italy. Joseph Colofiore's co-authors include Robert L. Stolfi, Daniel Martín, John Morrow, L. Dee Nord, David A. Rintoul, Robert C. Sawyer, Antonella Romanini, Joseph R. Bertino, Stephen S. Sternberg and J. A. Belli and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Genetics.

In The Last Decade

Joseph Colofiore

24 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Colofiore United States 13 198 152 42 34 32 24 329
Nicholas J. Combates United States 8 177 0.9× 155 1.0× 16 0.4× 22 0.6× 34 1.1× 12 365
Elke Malenke Germany 9 126 0.6× 82 0.5× 31 0.7× 24 0.7× 31 1.0× 13 303
Mehrad Tavallai United States 11 213 1.1× 129 0.8× 59 1.4× 23 0.7× 80 2.5× 15 376
Alessandro Barbarulo United Kingdom 12 224 1.1× 158 1.0× 23 0.5× 19 0.6× 17 0.5× 15 459
Anatoly Prokvolit United States 3 208 1.1× 134 0.9× 31 0.7× 20 0.6× 22 0.7× 3 332
Susan Wittig Germany 13 235 1.2× 120 0.8× 40 1.0× 27 0.8× 54 1.7× 25 387
Kathryn S. McKee United States 8 192 1.0× 187 1.2× 119 2.8× 16 0.5× 36 1.1× 12 457
Jocelin Pinto United States 4 239 1.2× 338 2.2× 105 2.5× 42 1.2× 17 0.5× 5 562
Julie Turzanski United Kingdom 11 145 0.7× 173 1.1× 9 0.2× 30 0.9× 13 0.4× 15 342
W. Hylton United Kingdom 12 76 0.4× 41 0.3× 25 0.6× 13 0.4× 42 1.3× 16 343

Countries citing papers authored by Joseph Colofiore

Since Specialization
Citations

This map shows the geographic impact of Joseph Colofiore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Colofiore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Colofiore more than expected).

Fields of papers citing papers by Joseph Colofiore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Colofiore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Colofiore. The network helps show where Joseph Colofiore may publish in the future.

Co-authorship network of co-authors of Joseph Colofiore

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Colofiore. A scholar is included among the top collaborators of Joseph Colofiore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Colofiore. Joseph Colofiore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nord, L. Dee, Robert L. Stolfi, Amauri Alcindo Alfieri, et al.. (1997). Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion. Cancer Chemotherapy and Pharmacology. 40(5). 376–384. 9 indexed citations
2.
Stolfi, Robert L., et al.. (1997). Perspective: The Chemotherapeutic Relevance of Apoptosis and a Proposed Biochemical Cascade for Chemotherapeutically Induced Apoptosis. Cancer Investigation. 15(4). 372–381. 22 indexed citations
3.
Stolfi, Robert L., et al.. (1996). Enhanced antitumor activity of an adriamycin + 5-fluorouracil combination when preceded by biochemical modulation. Anti-Cancer Drugs. 7(1). 100–104. 5 indexed citations
4.
Nord, L. Dee, Robert L. Stolfi, Joseph Colofiore, & Daniel Martín. (1996). Correlation of retention of tumor methylmercaptopurine riboside-5′phosphate with effectiveness in CD8F1 murine mammary tumor regression. Biochemical Pharmacology. 51(5). 621–627. 4 indexed citations
5.
Stolfi, Robert L., et al.. (1996). Marked enhancement in vivo of paclitaxel??s (taxol??s) tumor-regressing activity by ATP-depleting modulation. Anti-Cancer Drugs. 7(6). 655–659. 12 indexed citations
6.
Martín, Daniel, Robert L. Stolfi, L. Dee Nord, & Joseph Colofiore. (1996). Enhancement of chemotherapeutically-induced apoptosis in vivo by biochemical modulation of poly (ADP-ribose) polymerase. Oncology Reports. 3(2). 317–22. 3 indexed citations
7.
Schwartz, Gary K., Leonard B. Saltz, Ephraim S. Casper, et al.. (1996). A phase I trial of a modified, dose intensive FAMTX regimen (High dose 5-fluorouracil + doxorubicin + high dose methotrexate + leucovorin) with oral uridine rescue. Cancer. 78(9). 1988–1995. 9 indexed citations
8.
Colofiore, Joseph, Robert L. Stolfi, L. Dee Nord, & Daniel Martín. (1995). Biochemical modulation of tumor cell energy IV. Biochemical Pharmacology. 50(11). 1943–1948. 15 indexed citations
9.
Hudes, Gary R., James M. Brennan, John Hoffman, et al.. (1995). Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside. Cancer Chemotherapy and Pharmacology. 37(3). 229–234. 3 indexed citations
10.
Martín, Daniel, Robert L. Stolfi, Joseph Colofiore, L. Dee Nord, & Stephen S. Sternberg. (1994). Biochemical Modulation of Tumor Cell Energy in Vivo: II. A Lower Dose of Adriamycin is Required and a Greater Antitumor Activity is Induced when Cellular Energy is Depressed. Cancer Investigation. 12(3). 296–307. 27 indexed citations
11.
Seiter, Karen, Nancy E. Kemeny, Daniel Martín, et al.. (1993). Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-Aspartate, methotrexate, and leucovorin. Cancer. 71(5). 1875–1881. 29 indexed citations
12.
13.
Romanini, Antonella, et al.. (1992). Leucovorin Enhances Chtotoxicity of Trimetrexate/Fluorouracil, But Not Methotrexate/Fluorouracil, in CCRF-CEM Cells. JNCI Journal of the National Cancer Institute. 84(13). 1033–1038. 34 indexed citations
14.
O’Dwyer, Peter J., Joseph Colofiore, John Hoffman, et al.. (1991). Phase I Trial Of Fluorouracil Modulation by N-Phosphonacety-L-aspartate and 6-Methylmercaptopurine Riboside: Optimization of 6-Methylmercaptopurine Riboside Dose and Schedule Through Biochemical Analysis of Sequential Tumor Biopsy Specimens. JNCI Journal of the National Cancer Institute. 83(17). 1235–1240. 13 indexed citations
15.
Colofiore, Joseph, et al.. (1989). Effect of Uridine Diphosphoglucose on Levels of 5-Phosphoribosyl Pyrophosphate and Uridine Triphosphate in Murine Tissues. Pharmaceutical Research. 6(10). 863–866. 7 indexed citations
16.
Kemeny, Nancy E., Andrew M. Schneider, Daniel Martín, et al.. (1989). Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.. PubMed. 49(16). 4636–9. 9 indexed citations
17.
Colofiore, Joseph & Edith R. Schwartz. (1986). Monensin stimulation of arylsulfatase B activity in human chondrocytes. Journal of Orthopaedic Research®. 4(3). 273–280. 3 indexed citations
18.
Colofiore, Joseph, et al.. (1982). Enhanced survival of adriamycin-treated Chinese hamster cells by 2-deoxy-D-glucose and 2,4-dinitrophenol.. PubMed. 42(10). 3934–40. 19 indexed citations
19.
Colofiore, Joseph, John Morrow, & M. K. Patterson. (1973). ASPARAGINE-REQUIRING TUMOR CELL LINES AND THEIR NON-REQUIRING VARIANTS: CYTOGENETICS, BIOCHEMISTRY AND POPULATION DYNAMICS. Genetics. 75(3). 503–514. 13 indexed citations
20.
Morrow, John, Joseph Colofiore, & David A. Rintoul. (1973). Azaguanine resistant hamster cell lines not deficient in hypoxanthine‐guanine phosphoribosyl transferase. Journal of Cellular Physiology. 81(1). 97–100. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas J. Combates Breakdown of academic impact, for papers by Elke Malenke Breakdown of academic impact, for papers by Mehrad Tavallai Breakdown of academic impact, for papers by Alessandro Barbarulo Breakdown of academic impact, for papers by Anatoly Prokvolit Breakdown of academic impact, for papers by Susan Wittig Breakdown of academic impact, for papers by Kathryn S. McKee Breakdown of academic impact, for papers by Jocelin Pinto Breakdown of academic impact, for papers by Julie Turzanski Breakdown of academic impact, for papers by W. Hylton
Rankless by CCL
2026